SHA:601607 Revenue

Shanghai Pharmaceuticals Holding had revenue of 70.22B CNY in the quarter ending September 30, 2024, with 8.16% growth. This brings the company's revenue in the last twelve months to 272.42B, up 6.88% year-over-year. In the year 2023, Shanghai Pharmaceuticals Holding had annual revenue of 260.30B with 12.21% growth.

Revenue (ttm)

272.42B

Revenue Growth

+6.88%

P/S Ratio

0.27

Revenue / Employee

5.66M

Employees

48,164

Market Cap

65.33B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	260.30B	28.31B	12.21%
Dec 31, 2022	231.98B	16.16B	7.49%
Dec 31, 2021	215.82B	23.92B	12.46%
Dec 31, 2020	191.91B	5.34B	2.86%
Dec 31, 2019	186.57B	27.48B	17.27%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.93B
Yunnan Baiyao Group Co.,Ltd	39.34B
Beijing Wantai Biological Pharmacy Enterprise	2.49B

Revenue Rankings

Shanghai Pharmaceuticals Holding News

7 weeks ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
7 weeks ago - HUTCHMED to divest 45% stake in JV with Shanghai Pharma - Seeking Alpha

More News